Luisana Avilán

Luisana Avilán

Auto-generated profile, based on publicly available information

Luisana Avilán

Departamento de Biologia, Facultad de Ciencias, Universidad de Los Andes, Merida, Venezuela

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2011 in Enzyme Research
Verified
Journal Article
Open access
PDF file
LALuisana Avilán
Luisana Avilán
MGMelisa Gualdrón-López
Melisa Gualdrón-López
WQWilfredo A Quiñones
Wilfredo A Quiñones
LGLimari González-González
Limari González-González
VHVéronique Hannaert
Véronique Hannaert
JCJuan-Luis Concepción
Juan-Luis Concepción
Glycolysis and glyconeogenesis play crucial roles in the ATP supply and synthesis of glycoconjugates, important for the viability and virulence, respectively, of the human-pathogenic stages ofTrypanosoma brucei,Trypanosoma cruzi,andLeishmaniaspp. These pathways are, therefore, candidate targets for antiparasite drugs. The glycolytic/gluconeogenic enzyme enolase is generally highly conserved, with similar overall fold and identical catalytic residues in all organisms. Nonetheless, potentially important differences exist between the trypanosomatid and host enzymes, with three unique, reactive residues close to the active site of the former that might be exploited for the development of new drugs. In addition, enolase is found both in the secretome and in association with the surface ofLeishmaniaspp. where it probably functions as plasminogen receptor, playing a role in the parasite’s invasiveness and virulence, a function possibly also present in the other trypanosomatids. This location and possible function of enolase offer additional perspectives for both drug discovery and vaccination.

27 July 2007 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
GVGilmer Vanegas
Gilmer Vanegas
WQWilfredo A Quiñones
Wilfredo A Quiñones
César Carrasco-LópezCésar Carrasco-López
César Carrasco-López
JCJuan Luis Concepción
Juan Luis Concepción
Fernando AlbericioFernando Albericio
Fernando Albericio
LALuisana Avilán
Luisana Avilán

1 February 2014 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
AGAmaranta Gómez-Arreaza
Amaranta Gómez-Arreaza
HAHector Acosta
Hector Acosta
WQWilfredo A Quiñones
Wilfredo A Quiñones
JCJuan Luis Concepción
Juan Luis Concepción
PMPaul Michels
Paul Michels
LALuisana Avilán
Luisana Avilán

1 February 2004 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
LALaura Almeida
Laura Almeida
GVGilmer Vanegas
Gilmer Vanegas
MCMarina Calcagno
Marina Calcagno
JCJuan Luis Concepción
Juan Luis Concepción
LALuisana Avilan
Luisana Avilan
The ability of Trypanosoma cruzi to interact with plasminogen, the zimogenic form of the blood serin protease plasmin, was examined. Immunohistochemistry studies revealed that both forms, epimastigotes and metacyclic trypomastigotes, were able to fix plasminogen in a lysine dependant manner. This interaction was corroborated by plasminogen activation studies. Both forms of the parasite enhanced the plasminogen activation by tissue-type plasminogen activator.The maximal enhancements obtained were 15-fold and 3.4-fold with epimastigotes and metacyclic trypomastigotes, respectively, as compared to plasminogen activation in absence of cells. Ligand-blotting analysis of proteins extracted with Triton X-114 from a microsomal fraction of epimastigotes revealed at least five soluble proteins and one hydrophobic protein able to bind plasminogen

15 February 2012 in Malaria Journal
Verified
Journal Article
Open access
PDF file
ABAndreas Baumann
Andreas Baumann
MMMagda M Magris
Magda M Magris
MUMarie-Luz Urbaez
Marie-Luz Urbaez
SVSarai Vivas-Martinez
Sarai Vivas-Martinez
RDRommy Durán
Rommy Durán
WMWolfram G Metzger
Wolfram G Metzger
Background: Malaria transmission in most of Latin America can be considered as controlled. In such a scenario, parameters of baseline immunity to malaria antigens are of specific interest with respect to future malaria eradication efforts. Methods: A cross-sectional study was carried out in two indigenous population groups in Amazonas/Venezuela. Data from the regional malaria documentation system were extracted and participants from the ethnic groups of the Guahibo (n = 180) and Piaroa (n = 295) were investigated for the presence of Plasmodium parasites and naturally acquired antibodies to Plasmodium falciparum antigens in serum. The GMZ2 vaccine candidate proteins MSP3 and GLURP were chosen as serological markers. Results: The incidence of P. falcip arum in both communities was found to be less than 2%, and none of the participants harboured P. falciparum at the time of the cross-sectional. Nearly a quarter of the participants (111/475; 23,4%) had positive antibody titres to at least one of the antigens. 53/475 participants (11.2%) were positive for MSP3, and 93/475 participants (19.6%) were positive for GLURP. High positive responses were detected in 36/475 participants (7.6%) and 61/475 participants (12.8%) for MSP3 and GLURP, respectively. Guahibo participants had significantly higher antibody titres than Piaroa participants. Conclusions: Considering the low incidence of P. falciparum, submicroscopical infections may explain the comparatively high anti-P. falciparum antibody concentrations.

19 August 2011 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
PMPaul Michels
Paul Michels
LALuisana Avilán
Luisana Avilán
NAD+ plays multiple, essential roles in the cell. As a cofactor in many redox reactions it is key in the cellular energy metabolism and as a substrate it participates in many reactions leading to a variety of covalent modifications of enzymes with major roles in regulation of expression and metabolism. Cells may have the ability to produce this metabolite either via alternative de novo synthesis pathways and/or by different salvage pathways. In this issue of Molecular Microbiology, Gazanion et al. (2011) demonstrate that Leishmania species can only rely on the salvage of NAD+ building blocks. One of the enzymes involved, nicotinamidase, is absent from human cells. The enzyme is important for growth of Leishmania infantum and essential for establishing an infection. The crystal structure of the parasite protein has been solved and shows prospects for design of inhibitors to be used as leads for development of new drugs. Indeed, NAD+ metabolism is currently being considered as a promising drug target in various diseases and the vulnerability of Leishmania for interference of this metabolism has been proved in previous work by the same group, by showing that administration of NAD+ precursors has detrimental effect on the pathogenic, amastigote stage of this parasite.